𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Biochemical markers of bone turnover: potential use in the investigation and management of postmenopausal osteoporosis

✍ Scribed by P. Szulc; P. D. Delmas


Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
450 KB
Volume
19
Category
Article
ISSN
0937-941X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Effects of denosumab on bone turnover ma
✍ Richard Eastell; Claus Christiansen; Andreas Grauer; Stepan Kutilek; Cesar Liban πŸ“‚ Article πŸ“… 2011 πŸ› American Society for Bone and Mineral Research 🌐 English βš– 272 KB πŸ‘ 1 views

## Abstract Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the time course and determinants of bone turnover marker (BTM) response during denosumab treatment, the percentage of denosumab‐treat